GSK admits old Voltaren label was misleading

Bird & Bird 2018-02-19 8:43 pm By Christine Caulfield | Melbourne

Please login to bookmark

Drug giants GlaxoSmithKline and Novartis have conceded part of the ACCC’s case that packaging on their Voltaren Osteo Gel breached the Australian Consumer Law, but said the label was changed almost a year ago.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au